“Assessment of Pressor Effects of Drugs”—A New US FDA Draft Guidance for Industry

被引：0

|

作者：

J. Rick Turner

机构：

来源：

Therapeutic Innovation & Regulatory Science | 2018年 / 52卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：397 / 399

页数：2

相关论文

共 50 条

[41] Cardiovascular Mortality of Oral Antidiabetic Drugs Approved Before and After the 2008 US FDA Guidance for Industry: A Systemic Review and Meta-Analysis
Rashmi Goyat
Pragya Rai
Jongwha Chang
Charles D. Ponte
Xi Tan
Clinical Drug Investigation, 2018, 38 : 491 - 501
[42] Cardiovascular Mortality of Oral Antidiabetic Drugs Approved Before and After the 2008 US FDA Guidance for Industry: A Systemic Review and Meta-Analysis
Goyat, Rashmi
Rai, Pragya
Chang, Jongwha
Ponte, Charles D.
Tan, Xi
CLINICAL DRUG INVESTIGATION, 2018, 38 (06) : 491 - 501
[43] FDA position statement "Early Alzheimer's disease: Developing drugs for treatment, Guidance for Industry"
Sabbagh, Marwan N.
Hendrix, Suzanne
Harrison, John E.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2019, 5 (01) : 13 - 19
[44] Smallpox vaccine: FDA issues guidance for development of drugs to treat side effects
Reactions Weekly, 2004, 994 (1) : 2 - 2
[45] US FDA approve three new drugs for Type 2 diabetes
Bond, Theo
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2013, 8 (02) : 103 - 103
[46] US FDA approves three new drugs for Type 2 diabetes
Bond, Theo
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2013, 6 (02): : 101 - 101
[47] Comments on the Draft Guidance on oAdaptive Design Clinical Trials for Drugs and Biologicso of the US Food and Drug Administration
Brannath, Werner
Burger, Hans Ulrich
Glimm, Ekkehard
Stallard, Nigel
Vandemeulebroecke, Marc
Wassmer, Gernot
JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2010, 20 (06) : 1125 - 1131
[48] An Assessment of Concerns Regarding New Regulatory Guidance for Combination Products: A Review of the Submissions Made to the FDA Regarding Their Proposed Draft New Guidance on Human Factors Studies for a Combination Product in an Abbreviated New Drug Application
Philip T. Lance
Ruth V. Greenaway
Brian Edwards
Therapeutic Innovation & Regulatory Science, 2019, 53 : 254 - 263
[49] An Assessment of Concerns Regarding New Regulatory Guidance for Combination Products: A Review of the Submissions Made to the FDA Regarding Their Proposed Draft New Guidance on Human Factors Studies for a Combination Product in an Abbreviated New Drug Application
Lance, Philip T.
Greenaway, Ruth V.
Edwards, Brian
THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2019, 53 (02) : 254 - 263
[50] NICE publishes draft guidance on new tests for faster heart attack assessment
Wilson, Hannah
BIOMARKERS IN MEDICINE, 2014, 8 (06) : 878 - 878

← 1 2 3 4 5 →